Noah Kahan
★
d e v o n
$LAYYYTER
No title available
YOU ARE THE REASON
𓃗
"I'm Dorothy Gale from Kansas"
Kiana Khansmith
Sweet Seals For You, Always
EXPECTATIONS
TMBGareOK. The Official They Might Be Giants tumblr
No title available
Phantogram Three
art blog(derogatory)
Game Changer & Make Some Noise
I'd rather be in outer space 🛸
Lint Roller? I Barely Know Her
tannertan36
Love Begins
seen from United Kingdom
seen from Chile
seen from Türkiye
seen from United States
seen from United States
seen from Türkiye
seen from United States
seen from United States
seen from Philippines
seen from Malaysia
seen from Malaysia
seen from Türkiye
seen from Japan
seen from Türkiye
seen from Argentina
seen from Philippines
seen from Canada
seen from Colombia
seen from Pakistan
seen from Venezuela
@ramchintamaneni-blog
UK supermarket chain Waitrose & Partners has launched a new packaging-free retail concept at its renovated store in Wallingford. The…Read More…
UK supermarket chain Waitrose & Partners has launched a new packaging-free retail concept at its renovated store in Wallingford.
US-based BayCom Corp, the holding company for United Business Bank, and Grand Mountain Bancshares (GMB), the holding company for Grand Mountain Bank, FSB, have signed
Under the terms of the Agreement and Plan of Merger, GMB will be merged with and into BayCom, and Grand Mountain Bank with and into United Business Bank.
Nestlé Waters North America (NWNA) has announced the acquisition of bottled water distributor Watchung Spring Water in the US.
Nestlé Waters North America (NWNA) has announced the acquisition of bottled water distributor Watchung Spring Water in the US.
Dutch dairy cooperative FrieslandCampina has launched new resealable, fully recyclable packaging for its cheese. The new packaging will enable the…Read More…
Dutch dairy cooperative FrieslandCampina has launched new resealable, fully recyclable packaging for its cheese.
India’s Yes Bank has received a binding offer of $1.2bn financing from an unnamed global investor as it seeks to improve its capital flow. In
India’s Yes Bank has received a binding offer of $1.2bn financing from an unnamed global investor as it seeks to improve its capital flow.
HDFC, the parent company of Indian private-sector lender HDFC Bank, has acquired a 9.89% stake in Bandhan Bank. Under the transaction, HDFC received around 159.3
HDFC has acquired a 9.89% stake in Bandhan Bank receiving around 159.3 million Bandhan Bank shares, PTI reported citing a regulatory filing.
US-based nutrition provider Gerber and recycling company TerraCycle have partnered to recycle baby food packaging across the country. The two…Read More…
US-based nutrition provider Gerber and recycling company TerraCycle have partnered to recycle baby food packaging across the country.
Jumio has unveiled a real-time fully automated identity verification solution to identify and prevent deepfakes, bots and sophisticated spoofing attacks. Dubbed Jumio Go, the AI-powered
Jumio has unveiled a real-time fully automated identity verification solution Jumio Go to identify deepfakes, bots and sophisticated spoofing attacks.
Ban on sugary drinks at workplaces has shown positive health effects, according to a study conducted by the researchers at University of California San Francisco (UCSF) in the US.
Ban on sugary drinks at workplaces has shown positive health effects, according to a study conducted by the researchers at University of California San Francisco (UCSF) in the US.
Packaging company DS Smith has improved Morrisons’ Best Bacon packaging with its Retail Ready Packaging (RRP) solution that has 100%…Read More…
Packaging company DS Smith has improved Morrisons’ Best Bacon packaging with its Retail Ready Packaging (RRP) solution that has 100% recyclable fibre-based corrugated design.
The Bangko Sentral ng Pilipinas (BSP), the central bank of Philippines, is reportedly planning to grant domestic banks permission to set up Islamic banking business.
The central bank of the Philippines is considering granting permissions to domestic banks looking to set up Islamic banking business in the country.
Final results from the Phase III FLAURA trial investigating AstraZeneca’s Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC,
Final results from the Phase III FLAURA trial investigating AstraZeneca’s Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.
Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.....
Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.
Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options
Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options.
Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.
Final data from BMS’s Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.
Roche's Tecentriq: Results demonstrated that first-line treatment of patients with advanced non-small cell lung cancer and high programmed cell death ligand-1 expression who used Roche’s Tecentriq monotherapy resulted in improved overall survival compared with platinum-based chemotherapies.
Roche’s Tecentriq: Results demonstrated that first-line treatment of patients with advanced non-small cell lung cancer and high programmed cell death ligand-1 expression who used Roche’s Tecentriq monotherapy resulted in improved overall survival compared with platinum-based chemotherapies.
BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.
Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.